Related Experiment Video
Updated: Jan 8, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
Spike protein-induced VSIR-ISX signaling disrupts metabolic homeostasis and promotes COVID-19-related immune
Li-Ting Wang1, Shen-Nien Wang2,3,4,5, Shyh-Shin Chiou6,7
1Department of Life Science, National Taiwan Normal University, Taipei, Taiwan.
Abstract:
COVID-19 has caused millions of deaths worldwide since 2019. Vaccination has reduced both transmission and disease severity. However, emerging viral variants have weakened vaccine effectiveness, highlighting the need for new antiviral therapies. This study examines how the SARS-CoV-2-Spike protein (SARS-2-S) induces the VSIR-ISX signaling pathway, leading to metabolic disturbances that may worsen disease progression. Using RNA sequencing, we found that SARS-2-S expression in pulmonary cells activates genes involved in tryptophan and arachidonic acid (AA) metabolism, altering bioactive mediators like kynurenine and prostanoids, which are crucial for inflammation and immune responses. Mechanistically, the ACE2-MYD88 pathway, activated by SARS-2-S, enhances the VSIR-ISX axis through NF-κB signaling, driving these metabolic disruptions. Chromatin immunoprecipitation and genome sequencing revealed that ISX, activated via VSIR-MAPK signaling, upregulates enzymes involved in AA metabolism by binding directly to their gene promoters. Notably, disrupting the VSIR-ISX axis using shRNA interference or NF-κB inhibitors effectively mitigated these metabolic disturbances. Our findings suggest that the VSIR-ISX pathway could be a promising therapeutic target for treating COVID-19 by addressing virus-induced metabolic disruptions.
Insights
The SARS-CoV-2 Spike protein disrupts metabolism via the VSIR-ISX pathway, impacting tryptophan and arachidonic acid pathways. Targeting this axis offers a potential therapeutic strategy for COVID-19.
Area of Science:
- Molecular Biology
- Immunology
- Metabolic Research
Background:
- COVID-19, caused by SARS-CoV-2, has led to significant global mortality.
- Vaccine effectiveness is waning due to emerging viral variants, necessitating novel antiviral treatments.
- Understanding virus-host interactions is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the mechanism by which the SARS-CoV-2 Spike protein (SARS-2-S) induces metabolic disturbances.
- To identify the role of the VSIR-ISX signaling pathway in SARS-CoV-2-mediated metabolic alterations.
- To explore the VSIR-ISX pathway as a potential therapeutic target for COVID-19.
Main Methods:
- RNA sequencing to analyze gene expression changes in pulmonary cells.
- Chromatin immunoprecipitation and genome sequencing to identify ISX binding sites.
- Utilized shRNA interference and NF-κB inhibitors to disrupt the VSIR-ISX axis.
Main Results:
- SARS-2-S expression activates genes in tryptophan and arachidonic acid (AA) metabolism, altering kynurenine and prostanoid levels.
- The ACE2-MYD88 pathway, activated by SARS-2-S, enhances the VSIR-ISX axis via NF-κB signaling.
- ISX directly binds to gene promoters, upregulating enzymes involved in AA metabolism.
- Disruption of the VSIR-ISX axis mitigated SARS-2-S-induced metabolic disturbances.
Conclusions:
- The VSIR-ISX signaling pathway is a key mediator of SARS-CoV-2-induced metabolic dysregulation.
- Targeting the VSIR-ISX axis may offer a novel therapeutic strategy for managing COVID-19.
- Intervention in metabolic pathways offers a new avenue for antiviral therapy development.
More Related Videos
06:39High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells
Published on: April 21, 2022
10:39In Vitro Analysis of Myd88-mediated Cellular Immune Response to West Nile Virus Mutant Strain Infection
Published on: November 27, 2014
Related Concept Videos
The JAK-STAT Signaling Pathway
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Intracellular Signaling Cascades
TGF - β Signaling Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
PI3K/mTOR/AKT Signaling Pathway